𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estradiol decreases xanthine dehydrogenase enzyme activity and protein expression in non-tumorigenic and malignant human mammary epithelial cells

✍ Scribed by Gennaro Taibi; Giuseppe Carruba; Vitale Miceli; Letizia Cocciadiferro; Concetta M.A. Nicotra


Book ID
102301591
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
153 KB
Volume
108
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The retinoic acid deficiency in breast tumour epithelial cells has been ascribed to an insufficient expression of either the enzyme(s) involved in its biosynthesis or the cellular retinol binding protein (CRBP) or both. In an attempt to define the mechanisms underpinning retinoic acid deficiency in these cell model systems, we have investigated the potential regulatory effect of oestrogen (17β‐estradiol) on one key player in retinoic acid biosynthesis, the xanthine dehydrogenase (XDH). This enzyme is consistently expressed and very active in non‐malignant human mammary epithelial cells (HMEC), as opposed to tumour MDA‐MB231 and MCF7 cells. In these latter two cell lines, as opposed to HMEC cells, we observe a residual ability of XDH to produce retinoic acid from retinaldehyde and the inability to use retinol, as a consequence of a deficit in CRBP. In addition, estradiol treatment of MDA‐MB231 and MCF7 cells decreases protein expression and activity of the enzyme, with no modification of the mRNA transcript levels, eventually leading to deteriorate further retinoic acid production. J. Cell. Biochem. 108: 688–692, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


CCAAT/enhancer binding protein δ (C/EBPδ
✍ G.S. Sivko; D.C. Sanford; L.D. Dearth; D. Tang; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

## Abstract CCAAT/enhancer binding protein δ (C/EBPδ) plays a key role in mammary epithelial cell G~0~ growth arrest. C/EBPδ gene expression is down‐regulated in rodent mammary tumorigenesis and in human breast cancer, suggesting that “loss of function” alterations in C/EBPδ gene expression are com